vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and BEYOND MEAT, INC. (BYND). Click either name above to swap in a different company.
BEYOND MEAT, INC. is the larger business by last-quarter revenue ($61.6M vs $44.9M, roughly 1.4× AbCellera Biologics Inc.). On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -19.7%). AbCellera Biologics Inc. produced more free cash flow last quarter ($-44.6M vs $-49.8M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -9.7%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Beyond Meat, Inc., branded as Beyond, is a producer of plant-based meat alternatives founded in 2009 by Ethan Brown. The company's products were first launched in the United States in 2012.
ABCL vs BYND — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $61.6M |
| Net Profit | $-8.9M | — |
| Gross Margin | — | -11.5% |
| Operating Margin | -63.7% | -211.4% |
| Net Margin | -19.9% | — |
| Revenue YoY | 788.4% | -19.7% |
| Net Profit YoY | 73.9% | — |
| EPS (diluted) | $-0.03 | $0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $61.6M | ||
| Q3 25 | $9.0M | $70.2M | ||
| Q2 25 | $17.1M | $75.0M | ||
| Q1 25 | $4.2M | $68.7M | ||
| Q4 24 | $5.0M | $76.7M | ||
| Q3 24 | $6.5M | $81.0M | ||
| Q2 24 | $7.3M | $93.2M | ||
| Q1 24 | $10.0M | $75.6M |
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $-57.1M | $-110.7M | ||
| Q2 25 | $-34.7M | $-29.2M | ||
| Q1 25 | $-45.6M | $-52.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-51.1M | $-26.6M | ||
| Q2 24 | $-36.9M | $-34.5M | ||
| Q1 24 | $-40.6M | $-54.4M |
| Q4 25 | — | -11.5% | ||
| Q3 25 | — | 10.3% | ||
| Q2 25 | — | 11.5% | ||
| Q1 25 | — | -1.5% | ||
| Q4 24 | — | 13.1% | ||
| Q3 24 | — | 17.7% | ||
| Q2 24 | — | 14.7% | ||
| Q1 24 | — | 4.9% |
| Q4 25 | -63.7% | -211.4% | ||
| Q3 25 | -851.8% | -160.0% | ||
| Q2 25 | -290.2% | -46.6% | ||
| Q1 25 | -1479.6% | -81.8% | ||
| Q4 24 | — | -49.3% | ||
| Q3 24 | -1439.4% | -38.2% | ||
| Q2 24 | -1276.2% | -36.4% | ||
| Q1 24 | -551.5% | -70.7% |
| Q4 25 | -19.9% | — | ||
| Q3 25 | -637.8% | -157.6% | ||
| Q2 25 | -203.3% | -39.0% | ||
| Q1 25 | -1077.2% | -77.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -785.4% | -32.8% | ||
| Q2 24 | -504.3% | -37.0% | ||
| Q1 24 | -408.0% | -71.9% |
| Q4 25 | $-0.03 | $0.68 | ||
| Q3 25 | $-0.19 | $-1.44 | ||
| Q2 25 | $-0.12 | $-0.38 | ||
| Q1 25 | $-0.15 | $-0.69 | ||
| Q4 24 | — | $-0.65 | ||
| Q3 24 | $-0.17 | $-0.41 | ||
| Q2 24 | $-0.13 | $-0.53 | ||
| Q1 24 | $-0.14 | $-0.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $203.9M |
| Total DebtLower is stronger | — | $415.7M |
| Stockholders' EquityBook value | $966.9M | $-997.0K |
| Total Assets | $1.4B | $614.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $203.9M | ||
| Q3 25 | $83.2M | $117.3M | ||
| Q2 25 | $92.4M | $103.5M | ||
| Q1 25 | $159.3M | $102.1M | ||
| Q4 24 | $156.3M | $131.9M | ||
| Q3 24 | $126.6M | $121.7M | ||
| Q2 24 | $148.3M | $144.9M | ||
| Q1 24 | $123.6M | $157.9M |
| Q4 25 | — | $415.7M | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
| Q4 25 | $966.9M | $-997.0K | ||
| Q3 25 | $964.0M | $-784.1M | ||
| Q2 25 | $1.0B | $-677.0M | ||
| Q1 25 | $1.0B | $-649.5M | ||
| Q4 24 | $1.1B | $-601.2M | ||
| Q3 24 | $1.1B | $-611.9M | ||
| Q2 24 | $1.1B | $-590.0M | ||
| Q1 24 | $1.1B | $-561.4M |
| Q4 25 | $1.4B | $614.7M | ||
| Q3 25 | $1.4B | $599.7M | ||
| Q2 25 | $1.4B | $691.7M | ||
| Q1 25 | $1.3B | $643.8M | ||
| Q4 24 | $1.4B | $678.1M | ||
| Q3 24 | $1.4B | $692.9M | ||
| Q2 24 | $1.4B | $711.2M | ||
| Q1 24 | $1.5B | $735.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-46.8M |
| Free Cash FlowOCF − Capex | $-44.6M | $-49.8M |
| FCF MarginFCF / Revenue | -99.4% | -80.8% |
| Capex IntensityCapex / Revenue | 21.9% | 4.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-157.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $-46.8M | ||
| Q3 25 | $-52.6M | $-38.8M | ||
| Q2 25 | $-32.4M | $-33.2M | ||
| Q1 25 | $-11.6M | $-26.1M | ||
| Q4 24 | $-108.6M | $-29.0M | ||
| Q3 24 | $-28.9M | $-22.0M | ||
| Q2 24 | $-30.0M | $-16.0M | ||
| Q1 24 | $-41.7M | $-31.8M |
| Q4 25 | $-44.6M | $-49.8M | ||
| Q3 25 | $-61.5M | $-41.7M | ||
| Q2 25 | $-45.8M | $-35.1M | ||
| Q1 25 | $-22.2M | $-30.6M | ||
| Q4 24 | $-187.0M | $-35.4M | ||
| Q3 24 | $-47.4M | $-24.1M | ||
| Q2 24 | $-50.1M | $-17.3M | ||
| Q1 24 | $-65.8M | $-33.0M |
| Q4 25 | -99.4% | -80.8% | ||
| Q3 25 | -687.0% | -59.4% | ||
| Q2 25 | -267.9% | -46.9% | ||
| Q1 25 | -524.0% | -44.6% | ||
| Q4 24 | -3702.8% | -46.2% | ||
| Q3 24 | -728.4% | -29.7% | ||
| Q2 24 | -683.8% | -18.6% | ||
| Q1 24 | -661.5% | -43.7% |
| Q4 25 | 21.9% | 4.8% | ||
| Q3 25 | 99.7% | 4.1% | ||
| Q2 25 | 78.2% | 2.6% | ||
| Q1 25 | 251.1% | 6.5% | ||
| Q4 24 | 1552.7% | 8.4% | ||
| Q3 24 | 284.6% | 2.5% | ||
| Q2 24 | 274.6% | 1.4% | ||
| Q1 24 | 242.5% | 1.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
